Fundz

May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy

PRIVATEMay 13, 2024

Amount Raised

$25 Million

Round Type

Series B

ParisBiotechnologyHealth CareMedicalMedical Device

Investors

Kidron Capital Assets LPAvestria VenturesSofinnova PartnersTrill ImpactBpifrance

Description

May Health, a clinical-stage medical device company dedicated to helping those living with PCOS, has closed a $25 million Series B financing round, co-led by Bpifrance and Trill Impact with participation from founding investor Sofinnova Partners, as well as Avestria Ventures and Kidron Capital Assets LP. Funds will be used to support the company’s growth and advance its Ovarian Rebalancing™ therapy through the pivotal REBALANCE Study, evaluating its potential to address PCOS-related infertility.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as May Health that raised within 45 days of this round, from Fundz verified event records.

  • Ronovo Surgical raised $44M (Series B) on June 20, 2024.
  • Quantum Innovations raised $10M (Funding Round) on June 20, 2024.
  • Maximum Fidelity Surgical Simulations raised $2.2M (Seed) on June 17, 2024.
  • Hubly raised $1.3M on June 14, 2024.
  • Leo Cancer Care raised an undisclosed amount (Series C) on June 11, 2024.
  • Novocuff raised $6.8M on June 4, 2024.

Who to call at May Health, and when

A new round usually means May Health is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day May Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at May Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at May Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

May Health

Location

Paris, Ile-de-France, France

About

May Health is a clinical-stage medical device company dedicated to helping those living with the endocrine disorder polycystic ovary syndrome (PCOS).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment May Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAnne B., Vice President, MarketingSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for May Health's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

May Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.